ArticleThe Journal of biological chemistry2026
The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E. coli.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Environmental Persistence to Host Adaptation: Differential Curli Regulation inMicroorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional amyloids are a class of amyloids that serve important biological functions. One such bacterial functional amyloid is curli, assembled on the cell surface by Escherichia coli during biofilm biogenesis. Curli precursor proteins, CsgA and CsgB, synthesized in the cytoplasm, are highly amyloidogenic. It is imperative to keep the proteins in a soluble, non-aggregated form to prevent intracellular aggregation and cellular toxicity. Chaperones and chaperone-like proteins aid in solubility and proper translocation of curli subunits. Here, we have investigated a new functionality of a cytoplasmic protein, YedX, an E. coli transthyretin-related protein known to function as a hydrolase enzyme in purine metabolism. We established structure-influenced functional parallelism between YedX and CsgC, a chaperone-like protein that prevents immature aggregation of CsgA and CsgB in the periplasmic space. Our biophysical and biochemical studies suggest that YedX alleviates the in vitro amyloid assembly of CsgA, maintaining its native, soluble, and non-toxic state. Our findings unravel a novel function of YedX in keeping aggregation-prone proteins in the soluble state to aid protein homeostasis within the cell.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.